Clinical Studies

2) High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease.
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1998885

3) Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).
Haupt E, Ledermann H, Kopcke W.
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=15726875
&query_hl=3&itool=pubmed_docsum

4) Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study (BAP I Study).
http://alcalc.oxfordjournals.org/cgi/content/abstract/33/6/631

5) Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy. http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&uid=10219465&cmd=showdetailview&indexed=google

6) Diabetic polyneuropathy treatment by milgamma-100 preparation:
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=9791922&dopt=AbstractPlus

7) Therapeutic efficacy of "Milgamma" in patients with painful diabetic neuropathy.
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=pubmed&dopt=AbstractPlus&list_uids=9575643

8) A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy.
http://lib.bioinfo.pl/pmid:8886748

9) The Potential Role of Thiamine (Vitamin B1) in Diabetic Complications http://www.ingentaconnect.com/content/ben/cdr/2005/00000001/00000003/art00008;jsessionid=743cot7dkhql5.alice?
format=print&token=0044142cb28c4e6b63404f39412f415d482825622c494a5f2a737b43675f99588d2b

10) The Pathobiology of Diabetic Complications A Unifying Mechanism
http://diabetes.diabetesjournals.org/cgi/content/full/54/6/1615

11) High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1998885

12) Blood thiamine levels in outpatients with diabetes mellitus
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&dopt=AbstractPlus&list_uids=3451944

13) Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&
list_uids=12592403&query_hl=18&itool=pubmed_DocSum

14)Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications.
http://www.ncbi.nlm.nih.gov/pubmed/18581039